English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Proangiogenic factor signal transduction like vascular endothelial growth factor (VEGF), placental growth factor (PlGF) and tissue growth factor â-1 (TGFâ-1) are important to angiogenesis and vascular health in pregnancy. In preeclampsia (PE) concentration of fms-like tyrosine kinase-1 (sFlt-1) and soluble endoglin (sEng) are increase significantly. Base on analysis from resent research shown that sFlt-1 and sEng inhibit angiogenic factor signal transduction by competition in result angiogenic factor can‘t bind to their receptor. sFlt-1 and sEng are potential used as preeclampsia therapy because sFlt-1 and sEng have main role in PE pathogenesis. We suggest that the research to find out effective sFlt-1 and sEng antagonist have to conduct in the next time.

Antagonis Soluble Fms-Like Tyrosine Kinase 1 (sFlt-1) dan Soluble Endoglin (sEng) pada Preeklamsia